CAR T-Cell Therapy - Joshua Sasine, MD, PDH | Closer to a Cure Series

UCLA oncologist Joshua Sasine, MD, PhD, talks about the latest advancements in CAR T-cell therapy at UCLA. Learn more: www.uclahealth.org/closer-to-...

[@nehalrevuri8003]

17:46 While it is true that B-cells are not a priority for survival, their function (producing antibodies) makes them a vital part of the immune system in the long-term. Such a CAR-T cell system would kill the cancerous B-cells but would also kill healthy B-cell tissue, leading to B-cell aplasia and reducing patient immunity over the long term. You may have saved them from cancer, but if relapse or any other illnesses were to emerge, patients would be much more at risk.

[@InfiniteUniverse88]

To see what CAR really looks like, the protein data bank and PyMol is needed.

[@emilyhunt2129]

What do you do if you are told Dr can’t reach the cancer cells in the liver to have the CAR T Cell treatment available to you.

[@rickykohkoh9758]

How much is the treatment cost for using cart CD19 ?